From permissive MIT and Apache agreements to copyleft GPL frameworks, we broker the full spectrum of software licensing. Each agreement is crafted to balance creator rights with community access, ensuring your code reaches the world on your terms.
Enterprise licensing demands precision. We negotiate volume agreements, SaaS terms, perpetual versus subscription models, and redistribution rights. Every clause is deliberated, every obligation documented with editorial exactitude.
Synchronisation licences, mechanical royalties, performance rights, and master use agreements. We navigate the layered world of music licensing where every note carries legal weight.
Rights-managed imagery, editorial usage agreements, and fine art reproduction licences. Each image carries provenance, and we ensure that provenance translates to fair, transparent agreements.
Translation rights, territorial publishing agreements, serialisation licences, and digital distribution terms. The written word deserves contracts written with equal craft and care.
The architecture of innovation, brokered.
Patent licensing sits at the intersection of technology and law, where breakthrough inventions meet the frameworks that govern their use. Our brokerage approaches each patent portfolio as a narrative -- the inventor's journey from concept to claims, the licensee's need for technological advantage, and the delicate negotiation between exclusivity and accessibility.
We handle utility patents, design patents, and provisional agreements across jurisdictions. Whether you are licensing-in to build upon existing innovation or licensing-out to monetise your intellectual property portfolio, every term sheet we prepare reflects the gravity of what patents represent: the legal embodiment of human ingenuity.
The digital frontier demands new licensing paradigms. We broker agreements for tokenised intellectual property, smart contract licensing terms, and the evolving rights frameworks for digital collectibles and generative art.
Gene patents, compound licences, FRAND terms for essential biotechnology, and research collaboration agreements. In an industry where a single molecule can be worth billions, licensing precision is not optional -- it is foundational.